Lyme Treatment Risks: Antibiotics vs Untreated Infection
But untreated Lyme disease does too.
The real question is which risk matters more.
The risks of long-term antibiotics for Lyme disease are often discussed—but the risks of leaving the infection untreated are just as important.
In chronic Lyme disease, decisions are not about avoiding risk. They are about weighing one risk against another.
Risks of Long-Term Antibiotics for Lyme Disease
Antibiotics, especially over longer courses, can cause side effects:
- Gastrointestinal upset and diarrhea
- Secondary infections such as C. difficile
- Yeast overgrowth
- Allergic reactions (rare)
- Microbiome disruption
Clinical reality: these risks are real—but typically manageable with monitoring and supportive care.
Risks of Leaving Lyme Disease Untreated
When Lyme disease is only partially treated or left untreated, the consequences can be more serious:
- Neurologic injury — nerve pain, facial palsy, cognitive decline
- Musculoskeletal damage — arthritis, joint erosion, chronic pain
- Autonomic dysfunction — dizziness, heart rate instability
- Neuroinflammation — brain fog, memory loss, slowed processing
Clinical pattern: symptoms may worsen gradually and become more difficult to reverse over time.
Why This Risk-Benefit Decision Matters
Medicine often involves balancing risks.
We prescribe anticoagulants despite bleeding risk. We use chemotherapy despite toxicity.
Lyme disease should be approached the same way.
The decision is not whether antibiotics carry risk—it is whether the risk of not treating is greater.
The real question isn’t whether antibiotics carry risk—it’s whether doing nothing carries more.
Making Lyme Treatment Safer
A safer approach does not mean avoiding treatment—it means using it thoughtfully.
This includes:
- Monitoring for side effects early
- Adjusting treatment based on response
- Supporting gut health during therapy
- Individualizing treatment plans
Goal: maximize benefit while minimizing harm.
The risks of long-term antibiotics for Lyme disease must be weighed against the risks of chronic infection. For some patients, the greater risk is undertreatment.
Final Thought
Lyme treatment decisions are not risk-free—but neither is inaction.
Key question: Which risk is greater—treatment, or leaving the illness unresolved?
Resources
- Delayed Lyme Treatment: Why Waiting Can Be the Wrong Call
- Lyme Disease Treatment: Our Approach
- ILADS Guidelines on Lyme Disease
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
